Liquid Biopsies: Emerging role and clinical applications in solid tumours - ScienceDirect
Foundation Medicine to launch liquid biopsy companion diagnostic following FDA approval - MedCity News
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer | Nature Communications
FDA Approves Blood Tests That Can Help Guide Cancer Treatment - NCI
Foundation Medicine Acquires Precision Oncology Company Lexent Bio
The Biggest Liquid Biopsy Company Files for IPO - Nanalyze
FoundationOne Liquid CDx
Foundation Medicine on X: "Learn from a panel of our Foundation Medicine colleagues in part 2 of the “Liquid Biopsy in Clinical Practice” webinar on Tuesday, November 29th at 10:00 a.m. ET.
Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate Liquid Biopsy Research and Development, and Advance Cancer Care
![Foundation Medicine review - 7 facts you should know [DEC 2021]](https://nebula.org/blog/wp-content/uploads/2021/12/FoundationOne-CDx-testing-kit.png "Foundation Medicine review - 7 facts you should know [DEC 2021]")
Foundation Medicine review - 7 facts you should know [DEC 2021]
FLASCO / Foundation Medicine Launches Blood-Based Liquid Biopsy, FoundationACT
Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy
FoundationOne Liquid CDx
FoundationOne Liquid CDx
92. Phil Stephens, Ph.D., CSO, Foundation Medicine- Session: Liquid Biopsy – Using the Right Tool for the Right Job on Vimeo
FDA approves Foundation Medicine pan-tumor liquid biopsy test
AACR 2019 – Foundation Medicine sets the scene for liquid biopsy approval | Evaluate
Liquid Biopsy for Cancer: Review and Implications for the Radiologist | Radiology
Foundation Medicine wins FDA OK for pan-cancer liquid biopsy test
Foundation Medicine acquires liquid biopsy developer Lexent Bio | Fierce Biotech
Liquid Biopsy Technologies Hasten Progress in Precision Oncology
Foundation Medicine receives FDA approval for pan-tumour biopsy test
Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire
Liquid Biopsy to Identify Actionable Genomic Alterations | American Society of Clinical Oncology Educational Book
FoundationACT | Exosome RNA
FoundationOne Liquid CDx
Introducing our next-generation liquid biopsy
Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company's Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer | Business Wire
